MedTrace Logo

Assessment of the Role of Probiotics in Prevention of Ventilator-Associated Pneumonia in Neonates

NCT07001163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-06-03

No results posted yet for this study

Summary

Evaluate the preventive value of probiotics on VAP among ventilated neonates.

Conditions

  • Ventilator Acquired Pneumonia

Interventions

DIETARY_SUPPLEMENT

Probiotic

Probiotic sachets contained 1× 109 colony-forming unit of Bifidobacterium Animalis subsp.lactis BB-12), were given via orogastric tube twice daily.

Sponsors & Collaborators

  • Lamiaa Khaled Zidan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-05-01
Completion
2024-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07001163 on ClinicalTrials.gov